ALKS
Alkermes plc
Company Overview
| Mkt Cap | $5.12B | Price | $30.70 |
| Volume | 2.02M | Change | -0.39% |
| P/E Ratio | 13.9 | Open | $30.70 |
| Revenue | $1.6B | Prev Close | $30.82 |
| Net Income | $367.1M | 52W Range | $25.17 - $36.45 |
| Div Yield | N/A | Target | $43.12 |
| Overall | 65 | Value | 80 |
| Quality | 57 | Technical | 60 |
No chart data available
Stock Overview
Updated DailyAlkermes plc (ALKS) is a leading Healthcare company in the Biotechnology industry, currently trading at $30.70 with a market capitalization of $5.12 billion. The stock is trading in the middle of its 52-week range, demonstrating average quality indicators with a MarketXLS quality score of 57.
Today's trading session shows ALKS with a volume of 2.02 million shares. The stock opened down 0.39% from yesterday's close of $30.82. Current analyst estimates project earnings of $1.51 per share for this year, with next year targeting $1.29.
ALKS demonstrates positive technical signals based on technical analysis. The company trades on the NGS exchange and operates alongside industry peers including ACOR, BMY, JNJ, PFE, AZN.
Key investment considerations for ALKS include solid overall investment characteristics. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 40.5%. The stock shows attractive valuation opportunity based on valuation analysis.
Analysis generated on November 3, 2025 at 07:34 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ALKS | $30.70 | -0.4% | 2.02M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |